Dipartimento di Studi Sociali e Politici, Università degli Studi di Milano, Milan, Italy.
J Eval Clin Pract. 2011 Aug;17(4):594-6. doi: 10.1111/j.1365-2753.2011.01709.x. Epub 2011 Jun 16.
A system approach termed P4 medicine has recently been proposed in the field of oncology. This approach has been advanced as an extension of what is usually called 'personalized' or 'genomic medicine'. P4 medicine creates effective predictive, personalized, preventive and participatory models to treat patients. In order to give more relevance to the behavioural component that impinges on the way individuals act to prevent, cope and react to illnesses, how they decide between different therapeutic options and interact with physicians and adhere to treatment, we propose that P4 medicine should be transformed into P5 medicine. The fifth P represents the psycho-cognitive aspects to be considered in order to empower the patient, increase his/her quality of life and transform him/her from a passive recipient into an active decision-maker in the treatment process.
近年来，肿瘤学领域提出了一种称为 P4 医学的系统方法。该方法被认为是通常所说的“个性化”或“基因组医学”的延伸。P4 医学旨在创建有效的预测、个性化、预防性和参与性模型来治疗患者。为了更加强调影响个人预防、应对和反应疾病方式的行为因素，以及他们如何在不同的治疗方案之间做出决策并与医生互动和坚持治疗，我们建议将 P4 医学转变为 P5 医学。第五个 P 代表了心理认知方面，旨在赋予患者权力，提高其生活质量，并将其从治疗过程中的被动接受者转变为积极决策者。
